Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist.

Source:http://linkedlifedata.com/resource/pubmed/id/17181143

J. Med. Chem. 2006 Dec 28 49 26 7603-6

Download in:

View as

General Info

PMID
17181143